What are the Historical Developments and Current Growth Metrics of the Metagenomic Sequencing Market?
The metagenomic sequencing market has seen considerable growth due to a variety of factors.
• The metagenomic sequencing market has seen rapid growth in recent years. It will rise from $2.13 billion in 2024 to $2.5 billion in 2025, at a CAGR of 17.5%.
Growth is attributed to increased government involvement, a growing number of metagenomics research projects, expanding applications in genomics and diagnostics research, research funding availability, and the development of NGS data analysis tools.
What Is The Projected Growth Of The Metagenomic Sequencing Template Market?
The metagenomic sequencing market is expected to maintain its strong growth trajectory in upcoming years.
• The metagenomic sequencing market is projected to reach $4.71 billion by 2029, growing at a CAGR of 17.1%.
Growth is driven by decreasing computational costs, the focus on novel biomolecule discoveries, high-throughput sequencing adoption, demand for personalized medicine, and increasing infectious disease prevalence. Trends include the use of advanced genomic technologies, augmented R&D funding, sequencing technology advancements, and big data NGS analysis.
What Are The Key Drivers Fueling Growth In The Metagenomic Sequencing Market?
The growing prevalence of infectious diseases is set to drive the metagenomic sequencing market. Infectious diseases caused by bacteria, viruses, fungi, or parasites are on the rise, exacerbated by weakened immune systems due to conditions like cancer or HIV. Metagenomic sequencing allows for the study of pathogens, antimicrobial resistance, and outbreaks. The Government of Canada reported an increase in rabies samples in late 2022, while the Centers for Disease Control and Prevention reported a 5.9% increase in tuberculosis cases from 2021 to 2022, highlighting the demand for metagenomic sequencing solutions.
What Are The Principal Market Segments In The Global Metagenomic Sequencing Industry?
The metagenomic sequencing market covered in this report is segmented –
1) By Product And Service: Reagents And Consumables, Instruments, Sequencing Services, Analysis And Data Interpretation Solutions
2) By Technology: 16S Rrna Sequencing, Shotgun Metagenomic Sequencing, Whole-Genome Sequencing And De Novo Assembly, Metatranscriptomics
3) By Application: Clinical Diagnostic, Environmental Remediation, Gut Microbe Characterization, Drug Discovery, Biofuel, Agriculture, Other Applications
Subsegments:
1) By Reagents And Consumables: DNA Or RNA Extraction Kits, Library Preparation Kits, Sequencing Kits, PCR And qPCR Reagents, Other Consumables (Buffers, Probes)
2) By Instruments: Next-Generation Sequencers (NGS), Third-Party Sequencers, Microarrays, Real-Time PCR Instruments
3) By Sequencing Services: Whole Genome Sequencing (WGS), 16S rRNA Sequencing, Shotgun Metagenomic Sequencing, Amplicon Sequencing, Metatranscriptomic Sequencing
4) By Analysis And Data Interpretation Solutions: Bioinformatics Software, Cloud-Based Data Analysis Services, Data Storage Solutions, Custom Analysis Tools, Data Interpretation Platforms
Pre-Book The Metagenomic Sequencing Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
What Emerging Trends Are Influencing The Growth Of The Metagenomic Sequencing Market?
Major corporations in the metagenomic sequencing sector are emphasizing the innovation of sequencing services in order to enhance accuracy, throughput, and economic efficiency. Sequencing services encapsulate cutting-edge genetic technologies that allow for the sequencing of longer DNA sequences, offering a more in-depth understanding of genetic structures than traditional short-read processes. For instance, in April 2024, Denmark's Clinical Microbiomics A/S, a biotechnology firm, initiated superior long-read sequencing services. With components such as 16S, ITS, 18S rRNA, custom gene sequencing, and detailed genomics and metagenomics, these services provide unmatched resolution and quality in microbe analysis. This in turn enables in-depth examination of microbial groups and aids in creating highly precise metagenome-assembled genomes.
Who Are the Key Players In The Metagenomic Sequencing Market?
Major companies operating in the metagenomic sequencing market are:
• F. Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Merck Co. & KGaA
• Eurofins Scientific SE
• PerkinElmer Inc.
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• QIAGEN N.V.
• Beijing Genomics Institute Group
• Azenta Inc.
• Promega Corporation
• Novogene Co. Ltd.
• Oxford Nanopore Technologies plc
• Zymo Research Corporation
• Metagenomi Inc.
• Psamogen Inc.
• IntegraGen SA
• Karius Inc.
• DNAStar Inc.
• Macrogen Inc.
• Takara Bio Inc.
• Arc Bio LLC
• Microsynth AG
• Computomics GmbH
• COSMOSID Inc.
• Phase Genomics Inc.
• Era7 Bioinformatics GmbH
What Are The Regional Insights Into The Metagenomic Sequencing Market?
North America was the largest region in the metagenomic sequencing market in 2023. Asia-Pacific is expected to be the fastest growing region in the market. The regions covered in the metagenomic sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
